Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – announced the appointment of Jeffrey Black as Senior Vice President and Chief Financial Officer […]

RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today announced that Executive Vice President and Chief Financial Officer Thomas A. Szlosek will be leaving the Company effective August 2, 2023 to pursue an opportunity outside […]

Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective immediately. “We would like to thank Yoshitake Saito for his leadership and assistance in completing the foundation of […]

VIENNA — Ribbon Biolabs, the DNA synthesis company, today announced the appointment of Jodi Barrientos as Chief Business Officer. With over 17 years of experience in industry-leading life science and diagnostics companies, Jodi Barrientos brings deep knowledge and expertise in commercial strategy, operations, and enterprise development focused on key synthetic biology and genomics markets. In […]

We’re excited to announce that Grace DeSantis has joined ONI as VP Biology & Chemistry. Grace will be driving our Bioware function, and leading our Applications Development and Chemistry teams between Oxford and San Diego. Grace joins us from her executive R&D role at Illumina, where she oversaw R&D, clinical product innovation and product development for 9 […]

Quantoom Biosciences S.A. (“Quantoom”), a Univercells company, is establishing a team in the United States. The company has appointed Oladimeji Fashola as Chief Technology Officer, and Business Development team of three. These crucial additions mark an exciting phase of growth for the company and underline its commitment to expanding its presence in the U.S. market. The fast […]

Marcus Kuhnert will step down as Chief Financial Officer and Member of the Executive Board after a successful nine-year tenure Helene von Roeder appointed Chief Financial Officer and Executive Board Member, effective July 1, 2023 Darmstadt, Germany – Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board […]

Nanologica AB (publ) has decided to focus on Chromatography and the management team is adapted to reflect the new business focus. In order to create the best conditions for success in preparative chromatography, the company’s operations are focused on Chromatography and the Drug Development operations are down-prioritized and placed in subsidiaries for future opportunities. The […]

Rainer Lehmann to step down as Chief Financial Officer later this year; Sartorius commences search process Göttingen — Sartorius’ Chief Financial Officer Rainer Lehmann will step down from his position by the end of October 2023 to pursue a new opportunity outside the company. The Supervisory Board of Sartorius AG has initiated a search process […]

Changes are afoot at Swiss company evitria: As of May, Dr. Stefan Schmidt will take over the helm of the company, which specializes in the production of recombinant antibodies for medicine and research. Since 2010, evitria, based in Schlieren near Zurich, has specialized in the production of antibodies and other proteins. Today, evitria, part of a group consisting […]